DAVID LANDAU: Open Payments
NPI 1346419884 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$241 in 6 payments from 5 companies in 2025. Trend: 2023 $110 · 2024 $341 · 2025 $241
Food & beverage: $241
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $151 |
| ABBVIE INC. | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
Products named: INGREZZA, VRAYLAR, CAPLYTA, TRINTELLIX, Jornay PM.
Industry payments across NM — which companies pay providers there.
